A new study found thatMen with heart problemscan benefit from taking an impotence drug like Viagra. Research has shown that sildenafil (Viagra) significantly reduces the risk of another heart attack. It can also extend the lifespan of men who already have cardiovascular disease.
Blood pressure lowering drug against impotence as a benefit for the heart
Men with coronary artery disease and who are receiving Viagra for impotence appear to live longer, researchers say. They also have a lower risk of another heart attack. This emerges from a study by the Karolinska Institutet in Sweden. Impotence can be an early warning sign of cardiovascular disease in healthy men. Doctors treat this condition with various medications, such as phosphodiesterase inhibitors, which stimulate blood flow. Because PDE5 inhibitors lower blood pressure, experts have previously advised men with coronary heart disease against them due to the risk of a heart attack. In their new study, researchers sought to compare the effects of alprostadil and PDE5 inhibitors in men with stable coronary artery disease. Patients should at least six months before starting treatmenterectile dysfunctionhave had either a heart attack, balloon dilatation or coronary artery bypass surgery. The research included 16,500 men who received PDE5 inhibitors and nearly 2,000 who took alprostadil.
The study shows that the men who received PDE5 inhibitors lived longer and had a lower risk of a new heart attack, heart failure, balloon dilatation and bypass surgery than those who received alprostadil. The protection was dose-dependent, so the more frequent the dose of the PDE5 inhibitor, the lower the risk. This suggests that there is a causal relationship. However, according to the study authors, the analysis carried out cannot clearly confirm this theory. To determine whether it is the anti-impotence drug that reduces the risk, researchers had to randomly assign patients to two groups. One of them takes PDE5 while the other does not. The results thatthis studyhas provided, give scientists a very good reason to carry out further investigations. The research team hopes that men with coronary artery disease can discuss this matter with their doctor in the future.
